Breast cancer screenings still best for early detection

October 12, 2017

(HealthDay)—Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says.

"Breast can be treated more successfully if detected in its early phases, while it is small and has not yet spread," said Dr. Kathryn Evers, director of mammography at Fox Chase Cancer Center in Philadelphia. "With today's state-of-the-art treatment options and less extensive surgery, patients are experiencing better outcomes."

Older age is a leading risk factor for . Most women are diagnosed after the age of 50. Having certain mutations in the BRCA1 and BRCA2 genes also predispose women to the disease. And there are some lifestyle-related risk factors that can be controlled, such as hormone therapy after menopause, obesity, alcohol intake and physical inactivity, Evers said.

"Having one risk factor or even several doesn't mean a woman will definitely develop breast cancer," she said in a Fox Chase news release. "Women need to become educated about the , especially those they can control, and then adjust their lifestyle accordingly."

Not all women with breast cancer experience the same warning signs of the disease. Symptoms of breast cancer may include:

  • A lump in the breast or armpit.
  • Swelling or thickening in part of the breast.
  • Dimpling or irritation of the skin on the breast.
  • Pain in the breast that doesn't go away.
  • Redness or flaky skin on the breast or nipple.
  • Unusual nipple discharge.
  • A change in the size or shape of the breast.

In some cases, women never develop any of these symptoms, Evers noted.

"All women should know how their breasts look and feel so they can recognize any changes in them. This is an important part of breast health," she said. "But just being familiar with your breasts should never take the place of regular screenings and mammograms. These tests can help find breast cancer in its early stages, even before symptoms appear."

There are three tests often used to look for breast cancer, Evers said.

  • Mammogram: An X-ray of the breast used to examine breast changes. Its effectiveness depends on the size of a and the density of breast tissue. Three-dimensional (3-D) mammography involves X-ray machines that take pictures of thin slices of the breast from different angles, to build a 3-D image.
  • Breast ultrasound: This test is often used along with mammography to screen high-risk women and those with dense tissue.
  • Breast MRI: This test may be used to screen high-risk women and more closely examine a suspicious area detected during a mammogram or an ultrasound.

"I advise to speak with their physician to determine what is right for them," Evers said.

Explore further: Five things everyone should know about breast cancer

More information: The American Cancer Society has more about breast cancer.

Related Stories

Five things everyone should know about breast cancer

October 4, 2017
In 2017, the American Cancer Society estimates more than 250,000 new cases of breast cancer will be diagnosed in the United States, with more than 40,000 deaths. But progress in treatment and early detection has led to improved ...

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?

June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy ...

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

Most women unaware of breast density's effect on cancer risk, study finds

November 21, 2016
Most women don't know that having dense breasts increases their risk for breast cancer and reduces a mammogram's ability to detect cancer, according to a University of Virginia School of Medicine study.

Men develop breast cancer, too

July 8, 2014
(HealthDay)—While rare, breast cancer does occur in men and is often diagnosed at a later age and stage than in women, experts say.

Recommended for you

New findings explain how UV rays trigger skin cancer

October 18, 2017
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from ...

Drug yields high response rates for lung cancer patients with harsh mutation

October 18, 2017
A targeted therapy resurrected by the Moon Shots Program at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries ...

Possible new immune therapy target in lung cancer

October 18, 2017
A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but ...

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.